Metacon AB reports on option program

Report this content

Metacon today closed the subscription of its internal option program decided on the annual shareholder’s meeting 8 June.

All 6 500 000 share options that were offered to individuals in management and on the board of directors within category 1-3 according to the AGM decision were subscribed.

2 500 000 options are reserved for future recruitments.

The options that have now been subscribed will upon full future use result in a maximum dilution of 2,8%.

”I am happy to note the great interest in the option program and the strong internal belief in the future opportunities for Metacon in the hydrogen space that this is proving”, says Christer Wikner, President and CEO of Metacon.


For further information, please contact CEO Christer Wikner, phone +46 707-647389 or email:

About Metacon AB (publ)

Metacon AB (publ) develops and manufactures energy systems for the production of hydrogen, heat and electricity. The products are based on patented technology that produce hydrogen through reforming of biogas or other hydrocarbons, developed at the fully owned subsidiary Helbio in Greece. Helbio is a spin-off from the University of Patra and was founded by Professor Xenophon Verykios in 2001. From the very beginning, the business has focused on catalysts and advanced reforming solutions for highly efficient hydrogen production. The hydrogen can be used in the transport sector, industry and the real estate sector with a better environment and climate as a result. Through its associated company Water2H2, the market is also offered systems and solutions for the production of hydrogen through electrolysis.


Additional information may be found at | Twitter: @Metaconab | LinkedIn:

Metacon AB, Tomtebogatan 2, SE-703 43 Örebro, SWEDEN | Tfn: +46 586 740080 | E-post:


Documents & Links